다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

홈
인베스팅
주식
미국
USOTC
Revive Therapeutics Ltd (QB) (RVVTF)
Revive Therapeutics Ltd (QB) (RVVTF) 뉴스

RVVTF

Revive Therapeutics (QB) (RVVTF)

Revive Therapeutics Ltd (QB)

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:USOTC:RVVTF

일자	시간	출처	헤드라인	심볼	기업
2022/04/18	23:26	InvestorsHub NewsWire	Revive Therapeutics Announces Publication of Research Data with Bucillamine in COVID-19	USOTC:RVVTF	Revive Therapeutics Ltd (QB)
2022/04/12	21:00	InvestorsHub NewsWire	Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19	USOTC:RVVTF	Revive Therapeutics Ltd (QB)
2022/03/29	22:57	InvestorsHub NewsWire	Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19	USOTC:RVVTF	Revive Therapeutics Ltd (QB)
2022/02/24	22:35	InvestorsHub NewsWire	HAVN Life Secures Purchase Order for Controlled Substance Sale to Revive Therapeutics Ltd. for Use in Clinical Research	USOTC:RVVTF	Revive Therapeutics Ltd (QB)
2022/02/16	22:03	InvestorsHub NewsWire	Revive Therapeutics Receives FDA Orphan Drug Designation for Bucillamine in the Prevention of Ischemia-Reperfusion Injury During Liver Transplantation	USOTC:RVVTF	Revive Therapeutics Ltd (QB)
2022/02/14	20:53	InvestorsHub NewsWire	Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19	USOTC:RVVTF	Revive Therapeutics Ltd (QB)
2022/01/19	22:19	InvestorsHub NewsWire	Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19	USOTC:RVVTF	Revive Therapeutics Ltd (QB)
2022/01/17	23:13	InvestorsHub NewsWire	Revive Therapeutics Provides Update of Psilocybin Pharmaceutical Programs	USOTC:RVVTF	Revive Therapeutics Ltd (QB)
2022/01/07	22:05	InvestorsHub NewsWire	Revive Therapeutics Clarifies Status of Its Phase 3 Clinical Trial for Bucillamine in COVID-19	USOTC:RVVTF	Revive Therapeutics Ltd (QB)
2021/11/16	22:00	InvestorsHub NewsWire	Revive Therapeutics Announces Published Research Results on Bucillamine as Potential Inhibitor of SARS-CoV-2 Infection Delta Variant	USOTC:RVVTF	Revive Therapeutics Ltd (QB)
2021/09/22	20:30	InvestorsHub NewsWire	Revive Therapeutics Included in AdvisorShares® Newly Launched Psychedelics ETF	USOTC:RVVTF	Revive Therapeutics Ltd (QB)
2021/08/18	19:00	InvestorsHub NewsWire	Revive Therapeutics Signs Exclusive Worldwide License Agreement For Medicinal Mushroom Ganoderma Lucidum To Treat Cancer	USOTC:RVVTF	Revive Therapeutics Ltd (QB)
2021/08/12	22:56	InvestorsHub NewsWire	Revive Confirms No Material Undisclosed Information	USOTC:RVVTF	Revive Therapeutics Ltd (QB)
2021/08/10	21:52	InvestorsHub NewsWire	Revive Therapeutics Provides Update on Psychedelics Clinical Product Pipeline	USOTC:RVVTF	Revive Therapeutics Ltd (QB)
2021/07/16	03:47	InvestorsHub NewsWire	Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trialfor Bucillamine in COVID-19	USOTC:RVVTF	Revive Therapeutics Ltd (QB)
2021/06/28	21:00	InvestorsHub NewsWire	Revive Therapeutics Approved to Trade on the OTCQB Market	USOTC:RVVTF	Revive Therapeutics Ltd (QB)
2021/06/17	21:59	InvestorsHub NewsWire	Revive Collaborates With University of Health Sciences Antigua To Pioneer Clinical Research of Psychedelics	USOTC:RVVTF	Revive Therapeutics Ltd (QB)
2021/06/08	22:12	InvestorsHub NewsWire	Revive Therapeutics Partners with Supriya to Pursue EUA for Bucillamine to Treat COVID in India	USOTC:RVVTF	Revive Therapeutics Ltd (QB)
2021/05/17	22:48	InvestorsHub NewsWire	Revive Therapeutics Enters into Feasibility Agreement with LTS Lohmann to Develop Oral Psilocybin Thin Film Strip	USOTC:RVVTF	Revive Therapeutics Ltd (QB)
2021/05/03	22:32	InvestorsHub NewsWire	Revive Therapeutics Enters Into Research Agreement with UCSF For Bucillamine As Potential Treatment For Severe COVID-19	USOTC:RVVTF	Revive Therapeutics Ltd (QB)
2021/04/27	22:51	InvestorsHub NewsWire	Revive Therapeutics Files For FDA Orphan Drug Designation for Psilocybin in Traumatic Brain Injury	USOTC:RVVTF	Revive Therapeutics Ltd (QB)
2021/04/22	21:26	InvestorsHub NewsWire	Revive Therapeutics Announces Successful Research Results for Oral Thin Film Psilocybin and Filing of U.S. Provisional ....cont	USOTC:RVVTF	Revive Therapeutics Ltd (QB)
2021/03/24	22:15	InvestorsHub NewsWire	Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19	USOTC:RVVTF	Revive Therapeutics Ltd (QB)
2021/03/19	20:56	InvestorsHub NewsWire	Revive Therapeutics Announces Successful Research Results for Psilocybin to Treat Traumatic Brain Injury and Filing of ...Cont	USOTC:RVVTF	Revive Therapeutics Ltd (QB)
2021/02/26	23:01	InvestorsHub NewsWire	Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19 with Planned Completion...Cont	USOTC:RVVTF	Revive Therapeutics Ltd (QB)
2021/02/26	23:01	InvestorsHub NewsWire	Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19 with Planned Completion...Cont	USOTC:RVVTF	Revive Therapeutics Ltd (QB)
2021/02/17	23:53	InvestorsHub NewsWire	Revive Therapeutics Acquires Unique Psilocybin Assets	USOTC:RVVTF	Revive Therapeutics Ltd (QB)
2021/02/11	22:05	InvestorsHub NewsWire	Revive Therapeutics Provides Update on Cannabinoid Pharmaceuticals Program	USOTC:RVVTF	Revive Therapeutics Ltd (QB)
2021/01/27	22:13	InvestorsHub NewsWire	Revive Therapeutics in Phase 3 clinical trial for COVID-19 treatment	USOTC:RVVTF	Revive Therapeutics Ltd (QB)
2021/01/18	23:51	InvestorsHub NewsWire	How Combat Sports Are Researching Micro-Dosing Psychedelics To Treat Brain Injuries	USOTC:RVVTF	Revive Therapeutics Ltd (QB)

검색 관련기사 보기:USOTC:RVVTF

American Express

Financial Select Sector

Verizon Communications

Gold vs US Dollar

JP Morgan Chase

Invesco QQQ Trust Series 1

US Dollar vs Sterling

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관